The global market for breast cancer diagnostics is anticipated to reach a market value of $4.0 billion in 2022 and is expected to grow at a CAGR of 7% from 2022 to 2032 to reach a market value of $7.9 billion. The prevalence of breast cancer is rising, it is reoccurring, and there are more tests available, all of which are having a favorable effect on the need for breast cancer...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian